White Plains Hospital is the first U.S. site
to offer this innovative treatment to cancer patients
Tiltan Pharma Announces Enrollment of First U.S. Patient in a Phase 2 Clinical Trial of TL-118, Anti-Angiogenic Treatment for Metastatic Pancreatic CancerMoni Horovitz2022-08-25T08:57:48+00:00